Vineet Laboratories share news, announcements and annual reports
NSE: VINEETLABBSE: 543298Pharmaceuticals & BiotechnologySmall Cap
Vineet Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2021
Last close ₹37.76up ₹1.70 (4.71%)BSE ₹37.33
Share price at the NSE close on 29 Oct 2026. Previous close ₹36.06.
29 Oct: open ₹36.60, high ₹38.00, low ₹35.84
52-week range of traded prices to 29 Oct 2026
₹27.96Low, 9 Mar 2026₹49.99High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹73 Cr3,234th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 18.20
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹0.49 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 20.77
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.59
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.2%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹0.49 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 11.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.99
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 48,42264.9% delivered
Vineet Laboratories share news and announcements
209 announcements, routine notices left out, newest first. Page 4 of 5.
Aug 2023
12 Aug · Results
Jun 2023
May 2023
29 May · Results
18 May · Board meeting
Apr 2023
Feb 2023
23 Feb · Legal
Exchange has sought clarification from Vineet Laboratories Limited for the quarter ended 31-Dec-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is awaited.15 Feb · Results
Nov 2022
29 Nov · Related Party Transaction
Oct 2022
Sep 2022
29 Sep · Meeting
1 Sep · Legal
Exchange has sought clarification from Vineet Laboratories Limited with respect to announcement dated 30-Aug-2022 informing about Outcome of Board Meeting.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Brief profile (in case of appointment) The response of the company is awaited.1 Sep · Corporate action
Aug 2022
Jul 2022
Jun 2022
13 Jun · Related Party Transaction
May 2022
29 May · Results
28 May · Board meeting
Apr 2022
9 Apr · Legal
The exchange asked on 5 Apr 2022
Feb 2022
12 Feb · Results
12 Feb · Board meeting
4 Feb · Board meeting
Dec 2021
Nov 2021
10 Nov · Results
10 Nov · Board meeting
Oct 2021
Sep 2021